amitriptyline has been researched along with ethyl loflazepate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Abiko, Y; Chiba, I; Giri, S; Matsuoka, H; Paudel, D; Toyofuku, A; Uehara, O; Utsunomiya, M; Yoshida, K | 1 |
4 other study(ies) available for amitriptyline and ethyl loflazepate
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
Topics: Adult; Aged; Amitriptyline; Benzodiazepines; Burning Mouth Syndrome; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Milnacipran; Pain Management; Pain Measurement; Retrospective Studies | 2020 |